ApoCom provides a broad range of analysis and database search software systems for use in the discovery of new drug therapies, new chemical and agricultural products, and in the development of models to predict the fate, transport, and effects of natural and anthropogenic environmental stressors.

Specific services and products include:

• Software for use in Gene identification and sequencing,
• Electronic Lab Notebook software (offered by Rescentris),
• Gene sequence consulting,
• Database management and "mining" for commercial and government enterprises,
• Predictive risk modeling, and
• Research project management and consulting.

Select Product for more detail & on-line demos.

• GrailEXP™ - is an advanced and accurate analysis tool for computationally predicting genes and other DNA sequence features. While its primary use is to locate protein coding genes within DNA sequence, GrailEXP can also locate EST alignments, splice variants, promoters, polyadenylation sites, CpG islands, and repetitive elements... more Demo Pipeline

• Electronic Lab Notebook ApoCom Genomics has entered into a sales and distribution agreement with Rescentris Ltd, to offer Rescentris's suite of electronic laboratory notebook (ELN) products.  ELN provides information management solutions for collaborative life sciences research.  These leading products are designed to enhance an organization's return on investment related to R&D™.  The three core ELN products are CERF™ (Collaborative Electronic Research Framework™), CERF Notebook and the Genome Server Suite.

• Med-Genisys™ - The Medical Genetics Information System (MedGenisysÒ ) was instituted to give researchers, genomic and pharmaceutical companies access to normal and diseased tissues, body fluids and organs. MedGenisys has acquired the ability to access more than 360,000 patients from medical groups and other medical institutions in the United States. The objective of the program is to work with physicians and others to acquire tissue samples and body fluids from healthy patients and those presenting with chronic and genetic diseases. MedGenisys has implemented the required legal protection for protecting patients and other donors participating in this program. Researchers can request tissue and body fluid samples based upon their desired protocol and are assured that the samples were obtained legally and ethically. All samples obtained have vested with the providing entity an Informed Consent approved by the institutional review board to which the medical institution, physician practice group or other procurement organizations affiliated. Additionally, the researcher can request a medical history of the patient that will accompany the sample without revealing any patient identifiers or descriptors.

.